22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › Utah Medical Products, Inc. › 2024-2025

Utah Medical Products, Inc. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 20, 2026.

  • 6Reported items
  • 155Asset managers, any item
  • 602Fund votes
  • May 2, 2025Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Utah Medical Products, Inc. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Utah Medical Products, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Utah Medical Products, Inc. 2024-2025 meeting

155 asset managers disclosed a vote on at least one Utah Medical Products, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Utah Medical Products, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

To elect one director to serve a term expiring at the 2028 Annual Meeting and until a successor is…: Carrie Leigh

No official resultsDIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

10% of fund votes cast · no official result

WITHHOLD
Details: description as filed, votes by 59 asset managers

Description as filed by funds: To elect one director to serve a term expiring at the 2028 Annual Meeting and until a successor is elected and qualified: Carrie Leigh

The 59 asset managers below reported 96,397 for, 837,240 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 96,397WITHHOLD: 837,240
Largest asset managers voting on “To elect one director to serve a term expiring at the 2028 Annual Meeting and until a successor is elected and” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 0174,304Withhold
Dimensional00 0165,231Withhold
Fidelity00 092,190Withhold
BlackRock00 084,811Withhold
Datum One Series Trust00 064,427Withhold
JPMorgan00 059,199Withhold
Royce40,9460 00For
SEI00 027,535Withhold
HOTCHKIS & WILEY FUNDS /DE/00 025,900Withhold
WisdomTree21,4630 00For
Columbia Threadneedle17,8000 00For
ADVISORS SERIES TRUST00 015,343Withhold
Principal00 014,100Withhold
Prudential/PGIM00 012,497Withhold
Charles Schwab00 010,398Withhold
Equitable5,1000 05,197Mixed
CLEARWATER INVESTMENT TRUST00 09,927Withhold
TIAA00 08,839Withhold
American Century00 08,471Withhold
Russell Investments00 07,170Withhold
QUANTITATIVE MASTER SERIES LLC00 05,785Withhold
Empower00 05,700Withhold
State Street10 05,133Withhold
BRIDGEWAY FUNDS INC00 05,000Withhold
FORUM FUNDS II4,9380 00For

Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).

To approve, by advisory vote, the Company's executive compensation program.

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

99.7% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 80 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 25 asset managers voting on “To approve, by advisory vote, the Company's executive compensation program.” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock84,8110 00For
Datum One Series Trust64,4270 00For
JPMorgan59,1990 00For
SEI27,5350 00For
ADVISORS SERIES TRUST15,3430 00For
Charles Schwab10,3980 00For
CLEARWATER INVESTMENT TRUST9,9270 00For
Russell Investments7,1700 00For
QUANTITATIVE MASTER SERIES LLC5,7850 00For
FORUM FUNDS II4,9380 00For
ETF Series Solutions4,6900 00For
RBB FUND, INC.2,6280 00For
Global X1,9000 00For
John Hancock1,3480 00For
RBC FUNDS TRUST1,3000 00For
Jackson National1,1600 00For
Bridge Builder Trust1,0620 00For
TETON WESTWOOD FUNDS1,0000 00For
NORTHERN LIGHTS FUND TRUST II9400 00For
Nationwide5700 00For
NEW COVENANT FUNDS5150 00For
WILSHIRE MUTUAL FUNDS INC4980 00For
Gabelli3000 00For
Allianz2270 00For
Harbor ETF Trust890 00For

Fund voting reports, all 25 managers: 307,760 for.

Institutional-manager reports: 58 asset managers voting on “To approve, by advisory vote, the Company's executive compensation program.” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BRANDES INVESTMENT PARTNERS, LP181,9730 00For
RICE HALL JAMES & ASSOCIATES, LLC68,9190 00For
BlackRock66,8420 00For
Northern Trust30,5550 00For
SEI27,5800 00For
ISTHMUS PARTNERS, LLC26,5760 00For
Cardinal Capital Management21,5990 00For
Russell Investments13,0130 00For
Charles Schwab10,5550 00For
MARSHALL WACE, LLP7,9650 00For
LPL Financial LLC6,4220 00For
LSV ASSET MANAGEMENT5,147915 00Mixed
MERCER GLOBAL ADVISORS INC /ADV4,3720 00For
Penobscot Investment Management Company, Inc.4,0000 00For
Universal-Investment-Gesellschaft mbH3,3090 00For
Kovitz Investment Group Partners, LLC2,5150 00For
MACKENZIE FINANCIAL CORP2,3570 00For
Metis Global Partners, LLC2,0010 00For
OLD NATIONAL BANCORP /IN/1,5330 00For
NEW YORK STATE COMMON RETIREMENT FUND1,4290 00For
WASHINGTON STATE INVESTMENT BOARD1,0970 00For
ENVESTNET ASSET MANAGEMENT INC1,0290 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM0986 00Against
Community Bank & Trust, Waco, Texas7750 00For
PNC BANK, NATIONAL ASSOCIATION7580 00For

Institutional-manager reports, all 58 managers: 498,983 for, 2,109 against, 431 not voted. Showing the 25 largest; every one is in the interactive database (link above).

To hold an advisory vote on the Company's executive compensation program.

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 77 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 35 asset managers voting on “To hold an advisory vote on the Company's executive compensation program.” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard174,3040 00For
Dimensional165,2310 00For
Fidelity92,1900 00For
Royce40,9460 00For
HOTCHKIS & WILEY FUNDS /DE/25,9000 00For
WisdomTree21,4630 00For
Columbia Threadneedle17,8000 00For
Principal14,1000 00For
Prudential/PGIM12,4970 00For
Equitable10,2970 00For
TIAA8,8390 00For
American Century08,471 00Against
State Street5,1340 00For
BRIDGEWAY FUNDS INC5,0000 00For
Northern Trust3,8970 00For
Lincoln Financial2,7850 00For
Goldman Sachs2,3910 00For
Invesco1,6740 00For
AIG/SunAmerica1,6170 00For
Brighthouse1,2930 00For
SA FUNDS INVESTMENT TRUST1,2600 00For
Legg Mason1,0120 00For
ProShares8730 00For
Pacific Life7710 00For
Nationwide6280 00For

Fund voting reports, all 35 managers: 614,334 for, 8,471 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 55 asset managers voting on “To hold an advisory vote on the Company's executive compensation program.” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Renaissance194,2130 00For
GEODE CAPITAL MANAGEMENT, LLC100,5210 00For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC83,3700 00For
State Street72,1910 00For
Two Sigma36,1930 00For
Citadel25,8840 00For
Huber Capital Management LLC21,6360 00For
T. Rowe Price16,4770 00For
Dimensional16,3930 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC15,5830 00For
Newton Investment Management North America, LLC13,3940 00For
Victory Capital11,5100 00For
MELLON INVESTMENTS Corp10,5000 00For
Nuveen8,8890 00For
DE Shaw8,7500 00For
American Century08,471 00Against
GLOBEFLEX CAPITAL L P6,3360 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP5,3280 00For
AllianceBernstein5,1000 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC5,0000 00For
Maryland State Retirement & Pension System4,0440 00For
Vanguard3,2720 00For
Point722,7360 00For
Invesco2,5770 00For
Rhumbline1,9230 00For

Institutional-manager reports, all 55 managers: 684,122 for, 8,697 against. Showing the 25 largest; every one is in the interactive database (link above).

Advisory Vote to Ratify Named Executive Officers' Compensation

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 3 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 1 asset manager voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Empower5,7000 00For

Fund voting reports, all 1 managers: 5,700 for.

Institutional-manager reports: 2 asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan66,2580 00For
ALGERT GLOBAL LLC1,5200 00For

Institutional-manager reports, all 2 managers: 67,778 for.

To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending…

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending December 31, 2025; and

The 35 asset managers below reported 622,805 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 622,805
Largest asset managers voting on “To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year e” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard174,3040 00For
Dimensional165,2310 00For
Fidelity92,1900 00For
Royce40,9460 00For
HOTCHKIS & WILEY FUNDS /DE/25,9000 00For
WisdomTree21,4630 00For
Columbia Threadneedle17,8000 00For
Principal14,1000 00For
Prudential/PGIM12,4970 00For
Equitable10,2970 00For
TIAA8,8390 00For
American Century8,4710 00For
State Street5,1340 00For
BRIDGEWAY FUNDS INC5,0000 00For
Northern Trust3,8970 00For
Lincoln Financial2,7850 00For
Goldman Sachs2,3910 00For
Invesco1,6740 00For
AIG/SunAmerica1,6170 00For
Brighthouse1,2930 00For
SA FUNDS INVESTMENT TRUST1,2600 00For
Legg Mason1,0120 00For
ProShares8730 00For
Pacific Life7710 00For
Nationwide6280 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To ratify the selection of Haynie & Co. as the Company's independent registered public accounting firm for the year…

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 24 asset managers

Description as filed by funds: To ratify the selection of Haynie & Co. as the Company's independent registered public accounting firm for the year ending December 31, 2025.

The 24 asset managers below reported 305,132 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 305,132
Largest asset managers voting on “To ratify the selection of Haynie & Co. as the Company's independent registered public accounting firm for the” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock84,8110 00For
Datum One Series Trust64,4270 00For
JPMorgan59,1990 00For
SEI27,5350 00For
ADVISORS SERIES TRUST15,3430 00For
Charles Schwab10,3980 00For
CLEARWATER INVESTMENT TRUST9,9270 00For
Russell Investments7,1700 00For
QUANTITATIVE MASTER SERIES LLC5,7850 00For
FORUM FUNDS II4,9380 00For
ETF Series Solutions4,6900 00For
Global X1,9000 00For
John Hancock1,3480 00For
RBC FUNDS TRUST1,3000 00For
Jackson National1,1600 00For
Bridge Builder Trust1,0620 00For
TETON WESTWOOD FUNDS1,0000 00For
NORTHERN LIGHTS FUND TRUST II9400 00For
Nationwide5700 00For
NEW COVENANT FUNDS5150 00For
WILSHIRE MUTUAL FUNDS INC4980 00For
Gabelli3000 00For
Allianz2270 00For
Harbor ETF Trust890 00For

Largest Utah Medical Products, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 3,281,816 shares outstanding at the time of that meeting.

Fund voting reports: top Utah Medical Products, Inc. shareholders by shares voted on “To elect one director to serve a term expiring at the 2028 Annual Meeting and until a successor…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 5.31%
2Dimensional 5.03%
3Fidelity 2.81%
4BlackRock 2.58%
5Datum One Series Trust 1.96%
6JPMorgan 1.80%
7Royce 1.25%
8SEI 0.84%
9HOTCHKIS & WILEY FUNDS /DE/ 0.79%
10WisdomTree 0.65%
Institutional-manager reports: top Utah Medical Products, Inc. shareholders by shares voted on “To approve, by advisory vote, the Company's executive compensation program.”, 2024-2025
#Asset manager % of shares outstanding
1BRANDES INVESTMENT PARTNERS, LP 5.54%
2RICE HALL JAMES & ASSOCIATES, LLC 2.10%
3BlackRock 2.04%
4Northern Trust 0.93%
5SEI 0.84%
6ISTHMUS PARTNERS, LLC 0.81%
7Cardinal Capital Management 0.66%
8Russell Investments 0.40%
9Charles Schwab 0.33%
10MARSHALL WACE, LLP 0.24%

Reported Utah Medical Products, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Utah Medical Products, Inc. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BRANDES INVESTMENT PARTNERS, LP449,680 13.70%Schedule 13G, filed May 14, 2026
Renaissance Technologies217,714 6.63%Form 13F, quarter ended March 31, 2025
Dimensional Fund Advisors192,958 5.88%Form 13F, quarter ended March 31, 2025
Vanguard Group176,367 5.37%Form 13F, quarter ended March 31, 2025
BlackRock160,647 4.90%Form 13F, quarter ended March 31, 2025
Geode Capital107,776 3.28%Form 13F, quarter ended March 31, 2025
FMR LLC92,360 2.81%Schedule 13G, filed January 8, 2025
State Street80,150 2.44%Form 13F, quarter ended March 31, 2025
JPMorgan Chase72,329 2.20%Form 13F, quarter ended March 31, 2025
BNY Mellon48,612 1.48%Form 13F, quarter ended March 31, 2025

Percentages above are of 3,281,816 shares outstanding, as reported by Utah Medical Products, Inc. on its Form 10-K dated March 25, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Utah Medical Products, Inc.'s shareholder meeting held May 2, 2025, in the 2024-2025 proxy season, 155 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 602 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, by advisory vote, the Company's executive compensation program. — the reporting funds and managers cast 99.7% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Utah Medical Products, Inc.’s 10-K dated March 25, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Utah Medical Products, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “Utah Medical Products (UTMD) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/utah-medical-products-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.